Letter: prognostic scores in alcoholic hepatitis

Letter: scoring models in alcoholic hepatitis – authors' reply

“…Moreover, there may be criticism as to whether treatment effects could have led to the underestimation of predictive performances. 3 Recent results from the STOPAH trial, published in abstract form, suggest that treatment with glucocorticosteroids reduce the 28-day mortality only marginally. 4 Therefore, it is not surprising that a significant effect of glucocorticosteroids on survival was not shown in our relatively small cohort.…”